HCPLive
JUNE 7, 2025
Most modern GDMT components were prescribed to less than half of all patients included in the EMPACE study, indicating the need for strategies to enhance clinical adoption.
Med Page Today
JUNE 7, 2025
(MedPage Today) -- Hypertension kills more people than any other condition. In the U.S., despite spending more than $4 trillion a year on healthcare, less than half of people with hypertension have their condition controlled even to below 140/90.
HCPLive
JUNE 7, 2025
Khan’s presentation indicates that combination screening is the optimal method of identifying heart failure risk while minimizing the percentage of cases missed.
The American Journal of Cardiology
JUNE 7, 2025
Publication date: Available online 6 June 2025 Source: The American Journal of Cardiology Author(s): Waleed Alruwaili, Syed Ahmed, Seher Berzingi, Lalitsiri Atti, Amro Taha, Sittinun Thangjui, Harshith Thyagaturu, Sudarshan Balla
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
HCPLive
JUNE 7, 2025
An ERA 2025 analysis confirms empagliflozin significantly lowers acute kidney injury risk, reassuring clinicians about its safety in at-risk patients.
The American Journal of Cardiology
JUNE 7, 2025
Publication date: Available online 6 June 2025 Source: The American Journal of Cardiology Author(s): Rik Adrichem, Cindy Yang, Marcel L. Geleijnse, Mark M.P. van den Dorpel, Paul A. Cummins, Isabella Kardys, Joost Daemen, Rutger-Jan Nuis, Nicolas M.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
The American Journal of Cardiology
JUNE 7, 2025
Publication date: Available online 6 June 2025 Source: The American Journal of Cardiology Author(s): Yuichi Ozaki, Hironori Kitabata, Ryo Hikida, Yuta Takano, Yosuke Katayama, Masahiro Takahata, Teruaki Wada, Akira Taruya, Manabu Kashiwagi, Yasutsugu Shiono, Akio Kuroi, Takashi Tanimoto, Takashi Yamano, Atsushi Tanaka
HCPLive
JUNE 7, 2025
Pagidipati describes barriers to implementing guideline-directed medical therapy in patients with cardiometabolic diseases and steps needed to overcome them.
The American Journal of Cardiology
JUNE 7, 2025
Publication date: Available online 7 June 2025 Source: The American Journal of Cardiology Author(s): Yasuaki Takeji, Tomohiko Taniguchi, Takeshi Morimoto, Shinichi Shirai, Takeshi Kitai, Hiroyuki Tabata, Nobuhisa Ohno, Ryosuke Murai, Kohei Osakada, Koichiro Murata, Masanao Nakai, Hiroshi Tsuneyoshi, Tomohisa Tada, Masashi Amano, Shin Watanabe, Hiroki Shiomi, Hirotoshi Watanabe, Yusuke Yoshikawa, Ryusuke Nishikawa, Yuki Obayashi
HCPLive
JUNE 7, 2025
Study findings highlight the potential utility of cardiac catheterization as a targeted intervention in pre-kidney transplant cardiac risk stratification.
The American Journal of Cardiology
JUNE 7, 2025
Publication date: Available online 7 June 2025 Source: The American Journal of Cardiology Author(s): Tetsuma Kawaji, Takanori Aizawa, Issei Seto, Saki Yamano, Misaki Naka, Bingyuan Bao, Shun Hojo, Shintaro Matsuda, Masashi Kato, Takafumi Yokomatsu, Shinji Miki
HCPLive
JUNE 7, 2025
Discover groundbreaking insights on the VISIONARY trial, IgA nephropathy treatment, and the future of kidney care with expert Vlado Perkovic, MBBS, PhD.
Dr. Smith's ECG Blog
JUNE 7, 2025
A middle-aged man with a history of HOCM presented with 24 hours of chest pain, still active. He stated that he had been dehydrated for a day as well. The pain was not at all severe, and localized to the left sternal border, without radiation. The patient was in no distress and had normal vital signs. Here is his presentation ECG: What do you think?
HCPLive
JUNE 7, 2025
These phase 3b findings highlight lebrikizumab’s efficacy and safety in adult and adolescent patients with skin of color living with atopic dermatitis.
Medical Xpress - Cardiology
JUNE 7, 2025
Women, people from ethnic minority backgrounds, and those from the most deprived communities are less likely to receive treatment after a diagnosis of the heart valve disease aortic stenosis, according to research presented Tuesday at the British Cardiovascular Society conference in Manchester.
HCPLive
JUNE 7, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
HCPLive
JUNE 7, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
HCPLive
JUNE 7, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
HCPLive
JUNE 7, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
HCPLive
JUNE 7, 2025
The ACHIEVE trial found use of spironolcatone was not associated with a statistically significant reduction in cardiovascular death or hospitalization for HF.
HCPLive
JUNE 7, 2025
News Media Podcasts State Of Sciences - Presentations Videos Webinars Multimedia Series CURE Connections® Insights Medcast Peer Exchange Peers & Perspectives Special Report Conferences Conference Coverage Conference Listing Partners CME/CE Resources Digital Supplements Interactive Tools Live Events Press Release Publications Sponsored Advisory Board Subscribe Choose Specialty Allergy Allergy Allergy Allergy Biosimilars Cardiology Cardiology Cardiology Cardiology Cardiology Cardiology Cardiol
Expert insights. Personalized for you.
90 
Let's personalize your content